You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 40 No. 5, May 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cortisol Determination and the Dexamethasone Suppression Test

A Review

Herbert Y. Meltzer, MD; Victor S. Fang, PhD

Arch Gen Psychiatry. 1983;40(5):501-505.


Abstract



• The possibility that unreliability of plasma cortisol level determinations might interfere with the use of the dexamethasone suppression test (DST) in clinical practice was evaluated by examining published data on the reliability of plasma cortisol determinations as well as a comparison of two radioimmunoassay (RIA) methods with a competitive protein binding assay (CPBA). Significant discrepancies between various methods of plasma cortisol level determinations have been reported in most, but not all, studies. The most widely used method, RIA kits, may not produce levels comparable with those produced by the CPBA, used in a recent effort to standardize the DST for use in psychiatry. The use of the DST by physicians should be preceded by an assessment of the validity of the cortisol level determinations in the critical range for the DST by the laboratory they use.



Author Affiliations



From the Departments of Psychiatry (Drs Meltzer and Fang) and Medicine (Dr Fang), University of Chicago Pritzker School of Medicine, and the Illinois State Psychiatric Institute, Chicago (Dr Meltzer).


Footnotes



Accepted for publication Dec 2, 1982.

Reprint requests to Department of Psychiatry, University of Chicago Pritzker School of Medicine, 950 E 59th St, Chicago, IL 60637 (Dr Meltzer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dexamethasone Suppression Test Reversal in Rapid Transcranial Magnetic Stimulation-Treated Depression
Reid and Pridmore
Aust N Z J Psychiatry 1999;33:274-277.
ABSTRACT | FULL TEXT  

Maximizing Diagnostic Information From the Dexamethasone Suppression Test: An Approach to Criterion Selection Using Receiver Operating Characteristic Analysis
Mossman and Somoza
Arch Gen Psychiatry 1989;46:653-660.
ABSTRACT  

Plasma Cortisol Determination for the Dexamethasone Suppression Test: Comparison of Competitive Protein-Binding and Commercial Radioimmunoassay Methods
Ritchie et al.
Arch Gen Psychiatry 1985;42:493-497.
ABSTRACT  

Neurotransmitter Markers of Depression
Leonard
Aust N Z J Psychiatry 1984;18:307-312.
ABSTRACT  

Variability in Cortisol Level Assay Methods
Rubin and Poland
Arch Gen Psychiatry 1984;41:724-725.
ABSTRACT  

Effect of 5-Hydroxytryptophan on Serum Cortisol Levels in Major Affective Disorders: I. Enhanced Response in Depression and Mania
Meltzer et al.
Arch Gen Psychiatry 1984;41:366-374.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.